The eighth edition of The Life Sciences Law Review covers a total of 33 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. The chapters are arranged so as to describe requirements throughout the life cycle of a regulated product, from discovery to clinical trials, the marketing authorisation process and post-approval controls.
Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the regulatory framework in the life sciences sector in the United Arab Emirates.
Click here for the review >
This article was first published by Law Business Research Ltd in April 2020.